Novavax Joins Forces with the Gates Foundation’s Spin-off to Advance Malaria and TB Vaccinations

Novavax Joins Forces with the Gates Foundation’s Spin-off to Advance Malaria and TB Vaccinations

American vaccine manufacturer Novavax has announced plans to share its vaccine technology with the Bill & Melinda Gates Medical Research Institute. Novavax has signed a three-year deal to share its vaccine adjuvant, Matrix-M, with the nonprofit biotech, which aims to develop vaccines for major health threats such as malaria, tuberculosis, and Shigella. Adjuvants are crucial …

Read more